Pre-Malignant Skin Conditions: Actinic Keratosis (Solar Keratosis) Flashcards
Actinic Keratosis (Solar Keratosis) Lesion
ill-defined, scaly, erythematous papules or plaques on a background of sun-damaged skin (solar
heliosis)
Actinic Keratosis (Solar Keratosis) Palpation
sandpaper-like, gritty sensation felt on palpation, often easier to appreciate on palpation rather than
inspection
Actinic Keratosis (Solar Keratosis) sites
areas of sun exposure (face, ears, scalp if bald, neck, sun-exposed limbs)
Actinic Keratosis (Solar Keratosis) Pathophysiology
UV radiation damage to keratinocytes from repeated sun exposure (especially UVB)
UV-induced p53 gene mutation
Actinic Keratosis (Solar Keratosis) risk factors
increased age, light skin/eyes/hair, immunosuppression, syndromes such as albinism or
xeroderma pigmenotsum
Actinic Keratosis (Solar Keratosis) risk factors for malignancy
immunosuppression, history of skin cancer,
risk of transformation of AK to SCC (~1/1000), but higher likelihood if AK is persistent
Actinic Keratosis (Solar
Keratosis)
Epidemiology
common with increasing age, outdoor occupation, M>F
• skin phototypes I-III, rare in darker skin as melanin is protective
Actinic Keratosis (Solar Keratosis) Differential Diagnosis
SCC in situ, superficial BCC, seborrheic keratosis, cutaneous lupus erythematosus
Actinic Keratosis (Solar Keratosis) Investigations
biopsy lesions that are refractory to treatment
Actinic Keratosis (Solar Keratosis) Management • destructive:
cryotherapy, electrodessication, and curettage
Actinic Keratosis (Solar Keratosis) topical pharmacotherapy
mechanism: destruction of rapidly growing cells or immune system
modulation)
topical 5-fluorouracil cream (for 2-4 wk), imiquimod 5% (2x/wk for 16 wk), imiquimod 3.75%
(daily for 2 wk then none for 2 wk then daily for 2 wk), ingenol Mmbutate gel 0.015% (daily for 3 d
on the head and neck), ingenol mebutate 0.05% gel (daily for 2 d on the body)
Actinic Keratosis (Solar Keratosis) Management. alternative procedures
photodynamic therapy
• excision